Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
FRME
|
Michael J Fisher
Director |
BUY
Grant, award, or other acquisition
|
Direct | 538 Added 12.06% |
$14,833
$27.57 p/Share
|
Jun 30
2020 |
FRME
|
William L Hoy
Director |
BUY
Grant, award, or other acquisition
|
Direct | 538 Added 1.86% |
$14,833
$27.57 p/Share
|
Jun 30
2020 |
FRME
|
Michael R Becher
Director |
BUY
Grant, award, or other acquisition
|
Direct | 623 Added 4.36% |
$17,176
$27.57 p/Share
|
Jun 30
2020 |
FRME
|
Howard Halderman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 595 Added 4.54% |
$16,404
$27.57 p/Share
|
Jun 30
2020 |
FRME
|
H Douglas Chaffin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 557 Added 1.56% |
$15,356
$27.57 p/Share
|
Jun 30
2020 |
FRME
|
Michael C Marhenke
Director |
BUY
Grant, award, or other acquisition
|
Direct | 538 Added 1.51% |
$14,833
$27.57 p/Share
|
Jun 30
2020 |
FRME
|
Charles E Schalliol
Director |
BUY
Grant, award, or other acquisition
|
Direct | 821 Added 1.71% |
$22,635
$27.57 p/Share
|
Jun 30
2020 |
FRME
|
Gary Lehman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 538 Added 1.29% |
$14,833
$27.57 p/Share
|
Jun 30
2020 |
FRME
|
Michael J Stewart
President |
BUY
Grant, award, or other acquisition
|
Direct | 73 Added 0.11% |
$1,958
$26.82 p/Share
|
Jun 30
2020 |
FRME
|
Clark C Kellogg Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 538 Added 20.73% |
$14,833
$27.57 p/Share
|
Jun 30
2020 |
FRME
|
Patrick A Sherman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 566 Added 1.23% |
$15,605
$27.57 p/Share
|
Jun 30
2020 |
FRME
|
Jeffrey B Lorentson
Chief Audit Executive |
BUY
Grant, award, or other acquisition
|
Direct | 25 Added 0.19% |
$670
$26.82 p/Share
|
Jun 30
2020 |
AUB
|
Michael W Clarke |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 0.41% |
$45,000
$22.5 p/Share
|
Jun 30
2020 |
MDT
|
Omar Ishrak
Executive Chairman |
BUY
Bona fide gift
|
Indirect | 22,508 Added 50.0% |
-
|
Jun 30
2020 |
MDT
|
Omar Ishrak
Executive Chairman |
SELL
Bona fide gift
|
Direct | 22,508 Reduced 3.71% |
-
|
Jun 30
2020 |
INTC
|
Gregory M Bryant
EVP, GM, CCG |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 5.19% |
$293,550
$58.71 p/Share
|
Jun 30
2020 |
T
|
David S. Huntley
SEVP&Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 296 Added 2.21% |
$8,948
$30.23 p/Share
|
Jun 30
2020 |
T
|
Lori M Lee
Global Mktg Ofr & SEVP HR&Intl |
BUY
Grant, award, or other acquisition
|
Indirect | 248 Added 4.31% |
$7,497
$30.23 p/Share
|
Jun 30
2020 |
T
|
David R Mc Atee Ii
Sr. Exec. VP and Gen. Counsel |
BUY
Grant, award, or other acquisition
|
Indirect | 1,462 Added 2.14% |
$44,196
$30.23 p/Share
|
Jun 30
2020 |
T
|
Jeffery S. Mc Elfresh
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 672 Added 1.8% |
$20,315
$30.23 p/Share
|
Jun 30
2020 |
T
|
Angela Santone
Sr. Exec VP-Human Resources |
BUY
Grant, award, or other acquisition
|
Indirect | 297 Added 18.86% |
$8,978
$30.23 p/Share
|
Jun 30
2020 |
T
|
John Joseph Stephens
Sr. Exec. VP and CFO |
BUY
Grant, award, or other acquisition
|
Indirect | 1,293 Added 0.53% |
$39,087
$30.23 p/Share
|
Jun 30
2020 |
T
|
Randall L Stephenson
Exec Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Indirect | 1,976 Added 0.48% |
$59,734
$30.23 p/Share
|
Jun 30
2020 |
NKE
|
Mark G Parker
EXECUTIVE CHAIRMAN |
SELL
Payment of exercise price or tax liability
|
Direct | 105,426 Reduced 6.77% |
$10,337,020
$98.05 p/Share
|
Jun 30
2020 |
DIS
|
Maria Elena Lagomasino
Director |
BUY
Grant, award, or other acquisition
|
Direct | 432 Added 2.58% |
$49,140
$113.75 p/Share
|
Jun 30
2020 |
DIS
|
Mary T Barra
Director |
BUY
Grant, award, or other acquisition
|
Direct | 429 Added 10.15% |
$48,799
$113.75 p/Share
|
Jun 30
2020 |
DIS
|
Michael B. G. Froman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 429 Added 8.62% |
$48,799
$113.75 p/Share
|
Jun 30
2020 |
DIS
|
Susan E Arnold
Director |
BUY
Grant, award, or other acquisition
|
Direct | 417 Added 0.84% |
$47,434
$113.75 p/Share
|
Jun 30
2020 |
DIS
|
Derica W Rice
Director |
BUY
Grant, award, or other acquisition
|
Direct | 429 Added 11.9% |
$48,799
$113.75 p/Share
|
Jun 30
2020 |
DIS
|
Safra Catz
Director |
BUY
Grant, award, or other acquisition
|
Direct | 431 Added 6.13% |
$49,026
$113.75 p/Share
|
Jun 30
2020 |
DIS
|
Mark G Parker
Director |
BUY
Grant, award, or other acquisition
|
Direct | 429 Added 3.31% |
$48,799
$113.75 p/Share
|
Jun 30
2020 |
DIS
|
Francis A De Souza
Director |
BUY
Grant, award, or other acquisition
|
Direct | 429 Added 7.39% |
$48,799
$113.75 p/Share
|
Jun 30
2020 |
CMCSA
|
David C Novak
Director |
BUY
Grant, award, or other acquisition
|
Direct | 353 Added 0.11% |
-
|
Jun 30
2020 |
CMCSA
|
Naomi M. Bergman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 353 Added 4.64% |
-
|
Jun 30
2020 |
CMCSA
|
Edward D Breen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 353 Added 1.57% |
-
|
Jun 30
2020 |
CMCSA
|
Gerald L Hassell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 353 Added 1.09% |
-
|
Jun 30
2020 |
CMCSA
|
Jeffrey A Honickman
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 14 Reduced 0.01% |
$546
$38.98 p/Share
|
Jun 30
2020 |
CMCSA
|
Jeffrey A Honickman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 353 Added 0.26% |
-
|
Jun 30
2020 |
CMCSA
|
Asuka Nakahara
Director |
BUY
Grant, award, or other acquisition
|
Direct | 353 Added 3.74% |
-
|
Jun 30
2020 |
CMCSA
|
Maritza Gomez Montiel
Director |
BUY
Grant, award, or other acquisition
|
Direct | 353 Added 8.83% |
-
|
Jun 30
2020 |
AKUS
|
Novartis Bioventures LTD |
BUY
Open market or private purchase
|
Indirect | 125,000 Added 9.57% |
$2,125,000
$17.0 p/Share
|
Jun 30
2020 |
AKUS
|
Novartis Bioventures LTD |
BUY
Conversion of derivative security
|
Indirect | 1,056,258 Added 32.96% |
-
|
Jun 30
2020 |
ORCL
|
Edward Screven
Chief Corporate Architect |
SELL
Payment of exercise price or tax liability
|
Direct | 21,692 Reduced 0.91% |
$1,187,854
$54.76 p/Share
|
Jun 30
2020 |
ORCL
|
Edward Screven
Chief Corporate Architect |
BUY
Exercise of conversion of derivative security
|
Direct | 43,750 Added 1.81% |
-
|
Jun 30
2020 |
ORCL
|
Dorian Daley
EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Indirect | 10,072 Reduced 4.97% |
$551,543
$54.76 p/Share
|
Jun 30
2020 |
ORCL
|
Dorian Daley
EVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Indirect | 20,313 Added 9.11% |
-
|
Jun 30
2020 |
ORCL
|
W Corey West
Controller, EVP, CAO |
SELL
Payment of exercise price or tax liability
|
Direct | 7,747 Reduced 7.15% |
$424,226
$54.76 p/Share
|
Jun 30
2020 |
ORCL
|
W Corey West
Controller, EVP, CAO |
BUY
Exercise of conversion of derivative security
|
Direct | 15,625 Added 12.6% |
-
|
Jun 30
2020 |
AVGO
|
Justine Page
Director |
SELL
Open market or private sale
|
Direct | 260 Reduced 9.08% |
$80,587
$309.95 p/Share
|
Jun 30
2020 |
AVGO
|
Hock E Tan
President and CEO |
SELL
Open market or private sale
|
Direct | 57,171 Reduced 18.79% |
$17,889,378
$312.91 p/Share
|
Jun 30
2020 |